Crossmark

Inhibition of Neutrophil Elastase and Cathepsin G As a New Approach to the Treatment of Psoriasis: From Fundamental Biology to Development of New Target-Specific Drugs

Crossref DOI link: https://doi.org/10.1134/S1607672919040082

Published Online: 2019-09-26

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Krasavin, M. Yu.

Gureev, M. A.

Garabadzhiu, A. V.

Pashkin, A. Yu.

Zhukov, A. S.

Khairutdinov, V. R.

Samtsov, A. V.

Shvets, V. I.
License Information

Text and Data Mining valid from 2019-07-01

Version of Record valid from 2019-07-01
More Information

Article History

Received: 8 April 2019

First Online: 26 September 2019

COMPLIANCE WITH ETHICAL STANDARDS

: The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.

Document is current

Any future updates will be listed below